Kvacskay P, Hegenbart U, Lorenz H, Schonland S, Blank N
Ann Rheum Dis. 2024; 83(9):1200-1207.
PMID: 38653531
PMC: 11883751.
DOI: 10.1136/ard-2023-225114.
Hegazy M, Fayed A, Nuzzolese R, Sota J, Ragab G
Immunol Res. 2023; 71(4):578-587.
PMID: 36991303
PMC: 10425501.
DOI: 10.1007/s12026-023-09375-3.
Gromova M, Tsurko V
Mediterr J Rheumatol. 2021; 32(1):74-80.
PMID: 34386704
PMC: 8314881.
DOI: 10.31138/mjr.32.1.74.
Kobayashi H, Iwaide S, Ujike N, Murakami T
J Vet Med Sci. 2021; 83(6):935-939.
PMID: 33883362
PMC: 8267199.
DOI: 10.1292/jvms.21-0022.
Ponticelli C, Doria A, Moroni G
J Nephrol. 2020; 34(4):1081-1090.
PMID: 32548773
DOI: 10.1007/s40620-020-00776-3.
Olive Leaf Extract Attenuates Inflammatory Activation and DNA Damage in Human Arterial Endothelial Cells.
Burja B, Kuret T, Janko T, Topalovic D, Zivkovic L, Mrak-Poljsak K
Front Cardiovasc Med. 2019; 6:56.
PMID: 31157238
PMC: 6531989.
DOI: 10.3389/fcvm.2019.00056.
First case of pleural amyloidosis in systemic erythematosus: report and literature review.
Xiong J, Ren Y, Li H, Fu B, Wu R
Z Rheumatol. 2018; 77(9):841-843.
PMID: 30191392
DOI: 10.1007/s00393-018-0532-4.
Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report.
Yamagata A, Uchida T, Yamada Y, Nakanishi T, Nagai K, Imakiire T
BMC Nephrol. 2017; 18(1):377.
PMID: 29287589
PMC: 5747944.
DOI: 10.1186/s12882-017-0799-8.
Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.
Topaloglu R, Batu E, Orhan D, Ozen S, Besbas N
Pediatr Nephrol. 2015; 31(4):633-40.
PMID: 26563115
DOI: 10.1007/s00467-015-3249-5.
Amyloidosis in alkaptonuria.
Millucci L, Braconi D, Bernardini G, Lupetti P, Rovensky J, Ranganath L
J Inherit Metab Dis. 2015; 38(5):797-805.
PMID: 25868666
DOI: 10.1007/s10545-015-9842-8.
Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice.
Muhammad N, Murakami T, Inoshima Y, Ishiguro N
Clin Exp Immunol. 2015; 181(1):133-41.
PMID: 25736960
PMC: 4469163.
DOI: 10.1111/cei.12615.
Evaluation of serum amyloid a as a marker of persistent inflammation in patients with rheumatoid arthritis.
Agilli M, Aydin F, Cayci T, Kurt Y
Mediators Inflamm. 2015; 2015:843152.
PMID: 25694749
PMC: 4324919.
DOI: 10.1155/2015/843152.
Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis.
Lakota K, Carns M, Podlusky S, Mrak-Poljsak K, Hinchcliff M, Lee J
PLoS One. 2015; 10(1):e0110820.
PMID: 25629975
PMC: 4321755.
DOI: 10.1371/journal.pone.0110820.
Importance of serum amyloid-A in Behçet's disease.
Agilli M, Aydin F, Kurt Y, Cayci T
Clin Rheumatol. 2015; 35(2):551-2.
PMID: 25586523
DOI: 10.1007/s10067-014-2860-3.
Diagnosis of secondary amyloidosis in alkaptonuria.
Millucci L, Ghezzi L, Bernardini G, Braconi D, Lupetti P, Perfetto F
Diagn Pathol. 2015; 9:185.
PMID: 25567001
PMC: 4189149.
DOI: 10.1186/s13000-014-0185-9.
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
Real de Asua D, Costa R, Galvan J, Filigheddu M, Trujillo D, Cadinanos J
Clin Epidemiol. 2014; 6:369-77.
PMID: 25378951
PMC: 4218891.
DOI: 10.2147/CLEP.S39981.
Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.
Aguilera J, Zhang F, Beaudet J, Linhardt R, Colon W
Biochimie. 2014; 104:70-80.
PMID: 24878279
PMC: 4119840.
DOI: 10.1016/j.biochi.2014.05.007.
Incidence of Tuberculosis and Amyloidosis among Sudanese Patients Presented with Enlarged Nodes.
Agab Eldour A, Mohmed Salih E, Ahmed H
J Trop Med. 2014; 2014:832029.
PMID: 24799916
PMC: 3985298.
DOI: 10.1155/2014/832029.
Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases.
Hemminki K, Li X, Forsti A, Sundquist J, Sundquist K
BMC Med Genet. 2013; 14:88.
PMID: 24138840
PMC: 3766062.
DOI: 10.1186/1471-2350-14-88.
Pathophysiology and treatment of systemic amyloidosis.
Gillmore J, Hawkins P
Nat Rev Nephrol. 2013; 9(10):574-86.
PMID: 23979488
DOI: 10.1038/nrneph.2013.171.
